Precigen (PGEN) Change in Acquisitions & Divestments (2013 - 2026)
Precigen (PGEN) posted quarterly Change in Acquisitions & Divestments of $55.1 million for Q1 2026, up 1104.88% year-over-year from $4.6 million in Q1 2025, and down 13.56% quarter-over-quarter from $63.7 million in Q4 2025.
Analysis
Precigen (PGEN) Change in Acquisitions & Divestments (2013 - 2026) Analysis & Trends
Precigen (PGEN) has reported Change in Acquisitions & Divestments for 14 consecutive years, with $55.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments rose 1104.88% year-over-year to $55.1 million; the TTM figure through Mar 2026 stood at $259.0 million (up 93.27% YoY), while the FY2025 annual figure was $208.5 million, up 19.11% from the prior year.
- Change in Acquisitions & Divestments slipped to $55.1 million in Q1 2026 per PGEN's latest filing, from $63.7 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $82.3 million in Q3 2025 and bottomed at $4.6 million in Q1 2025.
- Historically, Change in Acquisitions & Divestments has averaged $40.6 million across 5 years, with a median of $45.6 million in 2024.
- Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments tumbled 89.97% — and 2026, when it jumped 1104.88%.
- Precigen's Change in Acquisitions & Divestments stood at $11.5 million in 2022, then soared by 297.67% to $45.6 million in 2023, then rose by 5.24% to $48.0 million in 2024, then soared by 32.74% to $63.7 million in 2025, then decreased by 13.56% to $55.1 million in 2026.
- Business Quant data shows PGEN's Change in Acquisitions & Divestments at $55.1 million in Q1 2026, $63.7 million in Q4 2025, and $82.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.75 Mn |
| Mar 31, 2026 | 55.10 Mn |
| Dec 31, 2025 | 63.74 Mn |
| Sep 30, 2025 | 82.27 Mn |
| Jun 30, 2025 | 57.88 Mn |
| Mar 31, 2025 | 4.57 Mn |
| Dec 31, 2024 | 48.02 Mn |
| Sep 30, 2024 | 29.66 Mn |
| Jun 30, 2024 | 51.75 Mn |
| Mar 31, 2024 | 45.58 Mn |
| Dec 31, 2023 | 45.63 Mn |
| Sep 30, 2023 | 35.90 Mn |
| Jun 30, 2023 | 43.94 Mn |
| Mar 31, 2023 | 57.91 Mn |
| Dec 31, 2022 | 11.47 Mn |
| Sep 30, 2022 | 20.97 Mn |
| Jun 30, 2022 | 18.00 Mn |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 18.17 Mn |
| Sep 30, 2021 | 24.00 Mn |